CClinicalTrials.gg
RecruitingNCT06312631ECO-HAND-AVCUpdated Jun 1, 2026

Home Grip Assistance Glove on the Use of the Upper Limb and Compliance Factors in Brain-injured Adults

An interventional study of Putting on the gripping glove and ULPA questionnaire in Stroke, sponsored by University Hospital, Toulouse. Recruiting at 1 site in France. Open to participants aged 18 Years to 90 Years. Per ClinicalTrials.gov, last updated 2026-06-01.

Sponsored by University Hospital, Toulouse · Not applicable, Interventional, and Other

From the registry’s dates

  • Started Mar 2024; still recruiting 2 years 6 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
18 Years to 90 Years
Sex
All
01

Study summary

On a functional level, performing the actions of daily life requires coordinated activity of the muscles of the upper limbs. The quality of motor recovery and/or technical assistance aimed at compensating for the movement deficit of the paretic upper limb (MSP) determines the possibilities of using the upper limb (MS) in activities of daily life.

Interventions in the chronic phase of stroke aim to return home. The integration of the paretic upper limb into daily life activities is a major issue regarding the prognosis of recovery of use of the upper limb. Independence in daily life becomes an ultimate goal to take charge of.

This study focuses on a new technical aid device, standard orthosis type, expanding the range of gripping gloves: the SaeboGlove in everyday environments. These MS orthoses help improve the use and function of the MSP in post-stroke adults as well as their independence and participation in society.

02

Conditions studied

  • Stroke

Browse trials for

Keywords

  • brain-injured adult
03

In context

Stroke

7,286 studies on the registry are indexed under Stroke; 2,007 are open to participants now.

This study's planned enrollment of 100 is above the median of 50 across 5,369 interventional studies indexed under Stroke.

Browse Stroke studies →

Lead sponsor

University Hospital, Toulouse is the lead sponsor of 794 studies on the registry; 214 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patient suffering from a motor deficit of the upper limb resulting from an ischemic or hemorrhagic stroke, hemispheric or brainstem, confirmed by brain imaging ;
  • Patient who suffered a stroke more than three months ago;
  • Patient unable to actively extend long fingers (hand opening) to voluntarily grasp an empty glass (upper and lower diameter of 7 and 6 cm respectively, height of 12 to 15 cm, weight of 125g, identical to equipment used for ARAT), with a palmar grip (cylindrical grip), while the subject can hold the previously placed glass passively in the hand;
  • Patient capable of passively opening the hand sufficient to grasp the glass when the gripping glove is put on, with the possibility of actively closing the hand;
  • Patient with the ability to put on and remove the SaeboGlove® gripping glove with the help of a third person if necessary and/or available.
  • Patient with a smartphone, tablet and/or computer compatible with video taking and teleconsultation.
  • Free, informed and signed consent by the participant and/or the person having guardianship and the investigator (at the latest on the day of inclusion and before any examination required by the research);
  • Person affiliated to or beneficiary of a social security system.

Exclusion criteria

Exclusion Criteria:

  • Patient presenting retraction or stiffness of the fingers and wrist preventing complete extension of the long fingers and thumb, the wrist being at 15° extension;
  • Patient with moderate or severe muscular spasticity of the wrist flexors and the long and short flexors of the fingers and thumb (Modified Ashworth Scale ≥ 3);
  • Patient with limited active elbow extension, not allowing the ipsilateral knee to be reached with the hand, the subject being seated with the trunk vertical (approach limitation);
  • Patient with an active anterior shoulder elevation range of less than 15°;
  • Patient with other upper limb deficiencies likely to influence participation;
  • Patient and/or entourage who do not have access to teleconsultation, and/or can be reached remotely;
  • Patient with severe aphasia, Boston Diagnostic Aphasia Examination (BDAE) ≤ 3;
  • Presence of moderate or severe edema localized to the wrist and hand;
  • Patient allergic to Latex
  • History of upper limb surgery less than 6 months old.
  • Pregnant and/or breastfeeding women
  • Patient deprived of liberty (detained/incarcerated);
  • Patient under judicial protection
  • Impossibility of giving the person informed information and ensuring the subject's compliance due to impaired physical and/or psychological health
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
100 participants (estimated)

Study arms

  • Experimental
    Task handover model #1

    At each visit, the patient will perform the tasks with the gripping glove (A) or without the gripping glove (B). The order of administration "with then without the glove (AB)" or "without then with the glove (BA)" is drawn at random for each patient. The 1st model follows the following diagram: Visit T1 = AB; Visit T2 = AB; Visit T3 = AB

    Device: Putting on the gripping glove · Other: ULPA questionnaire · Other: Motor Activity Log (MAL) Questionnaire · Other: Fugl-Meyer Assessment Upper Extremity (FMA-UE) questionnaire · Other: Score Action Arm Research Test · Other: EuroQol five-level (EQ-5D-5L) questionnaire · Other: Quebec User Evaluation of Satisfaction with Assistive Technology · Other: Psychosocial Impact of Assistive Devices Scale (PIADS) · Other: Goal Attainment Scale (GAS) · Other: installation and collection of accelerometers

  • Experimental
    Task handover model #2

    At each visit, the patient will perform the tasks with the gripping glove (A) or without the gripping glove (B). The order of administration "with then without the glove (AB)" or "without then with the glove (BA)" is drawn at random for each patient. The 2nd model follows the following diagram: Visit T1 = BA ; Visit T2 = AB ; Visit T3 = AB

    Device: Putting on the gripping glove · Other: ULPA questionnaire · Other: Motor Activity Log (MAL) Questionnaire · Other: Fugl-Meyer Assessment Upper Extremity (FMA-UE) questionnaire · Other: Score Action Arm Research Test · Other: EuroQol five-level (EQ-5D-5L) questionnaire · Other: Quebec User Evaluation of Satisfaction with Assistive Technology · Other: Psychosocial Impact of Assistive Devices Scale (PIADS) · Other: Goal Attainment Scale (GAS) · Other: installation and collection of accelerometers

  • Experimental
    Task handover model #3

    At each visit, the patient will perform the tasks with the gripping glove (A) or without the gripping glove (B). The order of administration "with then without the glove (AB)" or "without then with the glove (BA)" is drawn at random for each patient. The 3rd model follows the following diagram: Visit T1 = AB ; Visit T2 = BA ; Visit T3 = AB

    Device: Putting on the gripping glove · Other: ULPA questionnaire · Other: Motor Activity Log (MAL) Questionnaire · Other: Fugl-Meyer Assessment Upper Extremity (FMA-UE) questionnaire · Other: Score Action Arm Research Test · Other: EuroQol five-level (EQ-5D-5L) questionnaire · Other: Quebec User Evaluation of Satisfaction with Assistive Technology · Other: Psychosocial Impact of Assistive Devices Scale (PIADS) · Other: Goal Attainment Scale (GAS) · Other: installation and collection of accelerometers

  • Experimental
    Task handover model #4

    At each visit, the patient will perform the tasks with the gripping glove (A) or without the gripping glove (B). The order of administration "with then without the glove (AB)" or "without then with the glove (BA)" is drawn at random for each patient. The 4th model follows the following diagram: Visit T1 = AB ; Visit T2 = AB ; Visit T3 = BA

    Device: Putting on the gripping glove · Other: ULPA questionnaire · Other: Motor Activity Log (MAL) Questionnaire · Other: Fugl-Meyer Assessment Upper Extremity (FMA-UE) questionnaire · Other: Score Action Arm Research Test · Other: EuroQol five-level (EQ-5D-5L) questionnaire · Other: Quebec User Evaluation of Satisfaction with Assistive Technology · Other: Psychosocial Impact of Assistive Devices Scale (PIADS) · Other: Goal Attainment Scale (GAS) · Other: installation and collection of accelerometers

  • Experimental
    Task handover model #5

    At each visit, the patient will perform the tasks with the gripping glove (A) or without the gripping glove (B). The order of administration "with then without the glove (AB)" or "without then with the glove (BA)" is drawn at random for each patient. The 5th model follows the following diagram: Visit T1 = BA ; Visit T2 = BA ; Visit T3 = AB

    Device: Putting on the gripping glove · Other: ULPA questionnaire · Other: Motor Activity Log (MAL) Questionnaire · Other: Fugl-Meyer Assessment Upper Extremity (FMA-UE) questionnaire · Other: Score Action Arm Research Test · Other: EuroQol five-level (EQ-5D-5L) questionnaire · Other: Quebec User Evaluation of Satisfaction with Assistive Technology · Other: Psychosocial Impact of Assistive Devices Scale (PIADS) · Other: Goal Attainment Scale (GAS) · Other: installation and collection of accelerometers

  • Experimental
    Task handover model #6

    At each visit, the patient will perform the tasks with the gripping glove (A) or without the gripping glove (B). The order of administration "with then without the glove (AB)" or "without then with the glove (BA)" is drawn at random for each patient. The 6th model follows the following diagram: Visit T1 = BA ; Visit T2 = AB ; Visit T3 = BA

    Device: Putting on the gripping glove · Other: ULPA questionnaire · Other: Motor Activity Log (MAL) Questionnaire · Other: Fugl-Meyer Assessment Upper Extremity (FMA-UE) questionnaire · Other: Score Action Arm Research Test · Other: EuroQol five-level (EQ-5D-5L) questionnaire · Other: Quebec User Evaluation of Satisfaction with Assistive Technology · Other: Psychosocial Impact of Assistive Devices Scale (PIADS) · Other: Goal Attainment Scale (GAS) · Other: installation and collection of accelerometers

  • Experimental
    Task handover model #7

    At each visit, the patient will perform the tasks with the gripping glove (A) or without the gripping glove (B). The order of administration "with then without the glove (AB)" or "without then with the glove (BA)" is drawn at random for each patient. The 7th model follows the following diagram: Visit T1 = AB ; Visit T2 = BA ; Visit T3 = BA

    Device: Putting on the gripping glove · Other: ULPA questionnaire · Other: Motor Activity Log (MAL) Questionnaire · Other: Fugl-Meyer Assessment Upper Extremity (FMA-UE) questionnaire · Other: Score Action Arm Research Test · Other: EuroQol five-level (EQ-5D-5L) questionnaire · Other: Quebec User Evaluation of Satisfaction with Assistive Technology · Other: Psychosocial Impact of Assistive Devices Scale (PIADS) · Other: Goal Attainment Scale (GAS) · Other: installation and collection of accelerometers

  • Experimental
    Task handover model #8

    At each visit, the patient will perform the tasks with the gripping glove (A) or without the gripping glove (B). The order of administration "with then without the glove (AB)" or "without then with the glove (BA)" is drawn at random for each patient. The 8th model follows the following diagram: Visit T1 = BA ; Visit T2 = BA ; Visit T3 = BA

    Device: Putting on the gripping glove · Other: ULPA questionnaire · Other: Motor Activity Log (MAL) Questionnaire · Other: Fugl-Meyer Assessment Upper Extremity (FMA-UE) questionnaire · Other: Score Action Arm Research Test · Other: EuroQol five-level (EQ-5D-5L) questionnaire · Other: Quebec User Evaluation of Satisfaction with Assistive Technology · Other: Psychosocial Impact of Assistive Devices Scale (PIADS) · Other: Goal Attainment Scale (GAS) · Other: installation and collection of accelerometers

Interventions

  • DevicePutting on the gripping glove

    taking measurements and putting the gripping glove on the patient

  • OtherULPA questionnaire

    The evaluation of the effectiveness of the gripping glove on the performance of the upper limb in daily life will be evaluated using the ULPA score. The investigator asks the patient to perform a task and the ULPA collects the total number of errors made by the patient (inability/omission, imprecision, repetition, time to complete the task)

  • OtherMotor Activity Log (MAL) Questionnaire

    The MAL is a self-assessment of the integration of the upper limb into daily life. This measurement allows a quantified evaluation of the perceived performance of the use of the upper limb in the actions of daily life. The patient will answer 30 questions about daily life and for each item, rate the quantity from 0 to 5: 0 = never uses the hemiplegic arm and 5 = uses as much as before the accident

  • OtherFugl-Meyer Assessment Upper Extremity (FMA-UE) questionnaire

    This questionnaire assesses the motor selectivity of the upper limb. Several questions are asked about the movements that the patient can perform and to each question, the patient can answer either 0 (minimum) and 2 (maximum).

  • OtherScore Action Arm Research Test

    This questionnaire evaluates 4 different actions: Grasping an object (6 different objects to grasp), holding an object (4 different objects), pinching an object (6 different objects) and the overall movements made by the patient (3 different overall movements). For each item, each object or each movement evaluated, the patient must rate the task on a scale of 0 to 3 (0=cannot perform any part of the test and 3=performs the test normally)

  • OtherEuroQol five-level (EQ-5D-5L) questionnaire

    This questionnaire assesses the patient's state of health. 5 items are proposed (mobility, autonomy, current activity, pain, anxiety) and for each the patient must check one of the 5 propositions (no problem, mild problems, moderate problems, severe problems, incapable). The patient must also rate their state of health on a scale of 0 to 100.

  • OtherQuebec User Evaluation of Satisfaction with Assistive Technology

    This questionnaire assesses satisfaction with the technical aid (here the gripping glove) and the related services. The technique and related services will be evaluated by items provided to the patient and he will have to rate for each of them a score between 1 and 5 (1 = not satisfied at all and 5 = very satisfied)

  • OtherPsychosocial Impact of Assistive Devices Scale (PIADS)

    This questionnaire measures the effect of technical aids on the psychosocial level. 26 sentences or words are offered to the patient concerning his psychological state and the patient must evaluate them between -3 and 3 (-3 = decreased and +3: increased)

  • OtherGoal Attainment Scale (GAS)

    Carrying out an activity in the patient's real context is assessed using the Goal Attainment Scale (GAS). The doctor gives the patient objectives to achieve and the patient must give the quotation for each objective between initial state (-2), expected result (0) and best possible result (2)

  • Otherinstallation and collection of accelerometers

    The accelerometer quantitatively reports the spontaneous use of the upper limb in daily life. It counts the number of voluntary movements of the upper limbs. The amount of movement of the paretic upper limb will be expressed as a percentage of the movements of the non-paretic limb.

06

What researchers measure

Primary outcomes

  1. Evaluation of the effectiveness of the gripping glove

    The evaluation of the effectiveness of the gripping glove on the performance of the upper limb in daily life will be evaluated using the ULPA score and compared between the 2 conditions (with and without the glove) in the performance of a daily activity.

    Time frame: 6 months

Secondary outcomes

  1. Evaluation of the performance of an activity in the real context of the patient

    The performance of an activity in the real context of the patient will be evaluated using the GAS. Information is collected from the person and/or their entourage at each visit, assessed during visits T1 (14 days), T2 (3 months) and T3 (6 months) by the assessor (occupational therapist) from each center.

    Time frame: 6 months

  2. Evaluation of factual spontaneous use of the upper limb in daily life

    Factual spontaneous use of the upper limb in daily life will be measured using a wrist accelerometer. The movement will be compared between T0, T2 (3 months) and T3 (6 months).

    Time frame: 6 months

  3. Evaluation of the perceived performance of the use of the paretic upper limb

    The perceived performance of the use of the paretic upper limb will be evaluated using the MAL at T0, T2 (3 months) and T3 (6 months).

    Time frame: 6 months

  4. Assessment of the quality of voluntary motor skills of the upper limb

    The quality of voluntary motor skills of the upper limb will be assessed with the FMA at T0, T2 (3 months) and T3 (6 months), without wearing the gripping glove.

    Time frame: 6 months

  5. Assessment of gripping abilities

    Grasping abilities will be assessed by the ARAT at T0, T2 (3 months) and T3 (6 months), without wearing the gripping glove.

    Time frame: 6 months

  6. Quality of life assessment

    Quality of life, assessed using the EQ-5D-5L, will be explored at T0, T2 (3 months) and T3 (6 months).

    Time frame: 6 months

  7. Evaluation of satisfaction and tolerance

    Satisfaction and tolerance will be assessed by the patient with the QUEST version 2.0 questionnaire, at the end of the T3 visit (6 months).

    Time frame: 6 months

  8. Evaluation of the psycho-social impact

    The psycho-social impact will be assessed with the F-PIADS questionnaire during visits to T2 (3 months) T3 (6 months), by the evaluator (occupational therapist) from each center.

    Time frame: 6 months

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 1, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06312631
Lead sponsor
University Hospital, Toulouse
Responsible party
Sponsor
First posted
Mar 15, 2024
Start date
Mar 26, 2024
Primary completion
Dec 31, 2027 (estimated)
Completion
Dec 31, 2027 (estimated)
Last update
Jun 1, 2026

Study contacts

Claire VILLEPINTE
Contact
villepinte.c@chu-toulouse.fr
0567771724 ext. +33
Audrey TOMASIK
Contact
tomasik.a@chu-toulouse.fr
0561778597 ext. +33
Claire VILLEPINTE
principal investigator · University Hospital, Toulouse

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion